 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE-- COVID19--Twist Bioscience Corporation Nasdaq: TWST, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it will supply the U.S. Centers for Disease Control and Prevention CDC with a customized version of Twist SARS-CoV-2 Synthetic RNA Controls for use in the CDC Influenza SARS-CoV-2 Flu SC2 Multiplex Assay. The CDC SARS-CoV-2 Flu SC2 Multiplex Assay tests for influenza 